Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction to Pramiwel
Pramiwel (Pramipexole Tablets 1 mg) is a potent dopamine agonist designed to manage symptoms of Parkinson’s disease and restless legs syndrome (RLS). It works by mimicking the action of dopamine, a neurotransmitter crucial for movement regulation. Pramiwel helps restore dopamine balance, improving motor control and reducing discomfort associated with these neurological conditions.
Uses of Pramiwel
Parkinson’s Disease: Provides symptomatic relief by improving motor function, reducing tremors, and enhancing movement coordination.
Restless Legs Syndrome (RLS): Alleviates uncomfortable leg sensations, reducing the urge to move and improving sleep quality.
Benefits of Pramiwel
Enhances dopamine receptor stimulation for effective symptom control.
Reduces motor fluctuations and involuntary movements in Parkinson’s patients.
Relieves restlessness and discomfort in RLS, promoting restful sleep.
Well-tolerated with an established safety profile.
Mechanism of Action of Pramiwel
Pramiwel (Pramipexole) is a non-ergoline dopamine agonist that selectively binds to D2, D3, and D4 dopamine receptors, primarily stimulating the D3 subtype. This action enhances dopaminergic activity in the brain, counteracting dopamine deficiency seen in Parkinson’s disease and RLS. By improving dopamine signaling, Pramiwel effectively mitigates motor symptoms and abnormal limb sensations, offering sustained relief for patients.